Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003476465 | SCV004194880 | likely pathogenic | Bardet-Biedl syndrome 6 | 2024-02-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003779054 | SCV004609275 | pathogenic | Bardet-Biedl syndrome; McKusick-Kaufman syndrome | 2024-01-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe244Leufs*10) in the MKKS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MKKS are known to be pathogenic (PMID: 11179009, 28761321, 30614526). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MKKS-related conditions. For these reasons, this variant has been classified as Pathogenic. |
DNA- |
RCV003476465 | SCV005061820 | likely benign | Bardet-Biedl syndrome 6 | criteria provided, single submitter | clinical testing |